Related Experiment Video
Updated: Nov 8, 2025

Remote Laboratory Management: Respiratory Virus Diagnostics
Published on: April 6, 2019
A Crisis-Responsive Framework for Medical Device Development Applied to the COVID-19 Pandemic
Marc-Joseph Antonini1,2,3,4, Deborah Plana1,4,5, Shriya Srinivasan1,6,7,8
1Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, MA, United States.
None:
The disruption of conventional manufacturing, supply, and distribution channels during the COVID-19 pandemic caused widespread shortages in personal protective equipment (PPE) and other medical supplies. These shortages catalyzed local efforts to use nontraditional, rapid manufacturing to meet urgent healthcare needs. Here we present a crisis-responsive design framework designed to assist with product development under pandemic conditions. The framework emphasizes stakeholder engagement, comprehensive but efficient needs assessment, rapid manufacturing, and modified product testing to enable accelerated development of healthcare products. We contrast this framework with traditional medical device manufacturing that proceeds at a more deliberate pace, discuss strengths and weakness of pandemic-responsive fabrication, and consider relevant regulatory policies. We highlight the use of the crisis-responsive framework in a case study of face shield design and production for a large US academic hospital. Finally, we make recommendations aimed at improving future resilience to pandemics and healthcare emergencies. These include continued development of open source designs suitable for rapid manufacturing, education of maker communities and hospital administrators about rapidly-manufactured medical devices, and changes in regulatory policy that help strike a balance between quality and innovation.
More Related Videos
Related Concept Videos
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Acute Coronary Syndrome IV: Interprofessional Care
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Principles of Disease Surveillance
Preclinical Development: Overview
Acute Coronary Syndrome V: Nursing Management

